CPIX | Cumberland Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31
Revenue	39.55M	42.01M	35.99M	37.44M	34.39M	40.74M	41.15M	33.03M	33.52M	36.90M	32.03M	48.85M	51.14M	45.88M	43.54M	35.08M	28.06M	17.82M	10.69M
Cost of Revenue	11.00M	9.12M	8.81M	8.65M	7.42M	7.38M	7.37M	5.96M	4.97M	5.05M	5.44M	5.05M	5.36M	3.59M	4.14M	3.05M	2.67M	2.40M	533.26K
Gross Profit	28.55M	32.89M	27.17M	28.79M	26.97M	33.36M	33.78M	27.07M	28.55M	31.85M	26.59M	43.81M	45.78M	42.29M	39.40M	32.03M	25.39M	15.42M	10.16M
Operating Expenses	35.03M	38.60M	34.85M	35.17M	36.26M	40.75M	37.86M	28.50M	27.44M	28.29M	30.39M	34.99M	35.82M	35.68M	33.62M	24.75M	18.67M	13.19M	9.41M
Selling, General & Admin	29.20M	26.84M	24.80M	24.96M	25.25M	30.66M	31.52M	23.12M	21.60M	23.30M	23.88M	29.43M	30.14M	30.66M	27.84M	19.53M	14.19M	10.35M	8.24M
Research & Development	5.83M	6.69M	5.68M	5.77M	6.87M	7.32M	3.90M	3.19M	3.85M	3.39M	5.62M	5.10M	5.03M	4.33M	4.99M	4.43M	3.69M	2.23M	1.16M
Other Operating Expenses	2.83M	5.07M	4.37M	4.43M	4.13M	2.77M	2.44M	2.19M	1.99M	1.60M	896.16K	466.13K	655.30K	686.91K	793.68K	791.11K	783.43K	611.61K	13.49K
Operating Income	-6.48M	-5.70M	-7.68M	-6.38M	-9.29M	-7.39M	-4.08M	-1.43M	1.11M	3.56M	-3.80M	8.82M	9.96M	6.61M	5.78M	7.28M	6.73M	2.22M	749.92K
Other Expenses / Income	196.30K	123.74K	2.12M	-188.28K	-2.82K	368.64K	206.42K	98.27K	135.33K	184.37K	126.87K	232.88K	-252.12K	-1.33M	-693.56K	27.98K	-256.67K	-515.93K	20.40K
Before Tax Income	-6.28M	-5.58M	-5.56M	-6.57M	-9.29M	-7.02M	-3.87M	-1.33M	1.25M	3.74M	-3.67M	9.05M	9.71M	5.28M	5.08M	7.31M	6.47M	1.71M	770.32K
Income Tax Expenses	45.77K	68.85K	34.89K	55.90K	-79.32K	16.64K	4.17M	-330.92K	575.83K	1.38M	-1.52M	3.24M	4.08M	2.85M	2.02M	2.54M	2.42M	-2.70M	-1.18M
Net Income	-6.28M	-5.65M	-5.60M	-6.63M	-9.21M	-6.96M	-7.98M	-944.68K	731.35K	2.42M	-2.10M	5.84M	5.66M	2.46M	3.09M	4.77M	4.04M	4.40M	1.95M
Interest Expenses	667.86K	586.00K	98.03K	263.63K	246.19K	195.85K	92.90K	106.39K	73.86K	67.07K	103.42K	71.98K	353.50K	1.42M	772.93K	213.30K	639.59K	721.80K	63.20K
Basic Shares Outstanding	14.30M	14.56M	14.90M	15.16M	15.40M	15.61M	15.91M	16.24M	16.72M	17.62M	18.33M	19.56M	20.34M	20.33M	14.20M	10.14M	10.03M	9.80M	9.50M
Diluted Shares Outstanding	14.30M	14.56M	14.90M	15.16M	15.40M	15.61M	15.91M	16.24M	17.09M	17.90M	18.33M	19.79M	20.57M	21.06M	18.23M	16.54M	16.58M	16.03M	16.09M
EBITDA	-710.85K	-278.41K	-857.83K	-1.56M	-4.64M	-3.84M	-1.06M	1.23M	3.63M	5.86M	-2.22M	10.06M	11.13M	7.71M	6.71M	8.31M	7.87M	3.02M	887.06K
EBITDA Margin	-1.80%	-0.66%	-2.38%	-4.16%	-13.49%	-9.43%	-2.58%	3.72%	10.82%	15.88%	-6.94%	20.59%	21.77%	16.81%	15.40%	23.69%	28.05%	16.94%	8.30%
EBIT	-5.57M	-5.00M	-5.46M	-6.31M	-9.04M	-6.75M	-3.71M	-1.17M	1.38M	3.87M	-3.52M	9.16M	10.09M	6.73M	5.89M	7.52M	7.11M	2.43M	833.52K
EBIT Margin	-14.07%	-11.89%	-15.18%	-16.84%	-26.30%	-16.57%	-9.02%	-3.54%	4.12%	10.49%	-11.00%	18.75%	19.73%	14.67%	13.53%	21.45%	25.33%	13.64%	7.80%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31